Aprameya EngineeringNSE:APRAMEYA -1.15%41 OCF Margin % is 56.65% as of Mar. 2026. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 41/100. The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Aprameya Engineering ranks better than 99.39% on this metric.
The historical rank and industry rank for Aprameya Engineering's OCF Margin % or its related term are showing as below:
NSE:APRAMEYA'
s OCF Margin % Range Over the Past 10 Years
Min: -17.27 Med: -0.18 Max: 56.65
Current: 56.65
During the past 7 years, the highest OCF Margin % of Aprameya Engineering was 56.65%. The lowest was -17.27%. And the median was -0.18%.
NSE:APRAMEYA's OCF Margin % is ranked better than 99.39% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs NSE:APRAMEYA: 56.65
Aprameya Engineering OCF Margin % Related Terms
Aprameya Engineering OCF Margin % Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aprameya Engineering (NSE:APRAMEYA) has a OCF Margin % of 56.65% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aprameya Engineering and its competitors. According to the industry distribution chart, Aprameya Engineering ranks #5 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 0.59999999999999%.
Is Aprameya Engineering's OCF Margin % too high?
Aprameya Engineering's current OCF Margin % is 56.65%. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Aprameya Engineering's value of 56.65% is 866.7% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #5 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Aprameya Engineering has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #5 out of 815 companies for OCF Margin %. This places Aprameya Engineering in the top 1% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Aprameya Engineering's value of 56.65% is 866.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current OCF Margin % of 56.65% is 866.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current OCF Margin % is 56.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current OCF Margin % of 56.65%. The current OCF Margin % is 56.65% and 866.7% above the Medical Devices & Instruments industry median of 5.86. Aprameya Engineering's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current OCF Margin % is 56.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
41GF Score
Get the complete analysis for NSE:APRAMEYA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 